NCT06157424

Brief Summary

Gastroesophageal reflux disease (GERD) is increasingly prevalent today. Proton-pump inhibitors (PPIs) are the primary treatment, yet their effectiveness remains limited. Various acupuncture methods have shown promise in treating GERD. Among these, thread embedding acupuncture (TEA) and auricular acupuncture (AA) offer the advantage of prolonged treatment per intervention, significantly reducing healthcare visits for procedures, particularly beneficial for conditions requiring extended therapy. This has led to the widespread application of TEA and AA in GERD treatment. However, evidence supporting their effectiveness remains inconclusive. In this study, we aim to assess the efficacy and safety of combining TEA with AA for treating GERD. According to traditional medicine, treatment should be pattern-based. Thus, we will focus on patients exhibiting the Liver Qi Invading Stomach pattern, as reports indicate its prevalence among GERD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 5, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

December 6, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2024

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

3 months

First QC Date

November 27, 2023

Last Update Submit

March 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The proportion of heartburn resolution

    Heartburn resolution is assessed through patient inquiry during each follow-up examination.

    Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

Secondary Outcomes (6)

  • The proportion of regurgitation resolution

    Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

  • Chang in the Gastroesophageal Reflux disease Questionnaire (GerdQ) score

    Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

  • Chang in the Frequency Scale for the Symptoms of GERD (FSSG) score

    Day 0 and after every two week during 4-week treatment (day 0, day 14, day 28)

  • Chang in the Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQL) score

    Day 0 and after every two week during 4-week treatment (day 0, day 14, day 28)

  • Changes in the number of antacid packets used

    Day 0 and after every week during 4-week treatment (day 0, day 7, day 14, day 21, day 28)

  • +1 more secondary outcomes

Study Arms (2)

Acupuncture + Standard treatment

EXPERIMENTAL

Standard treatment plus thread embedding acupuncture and auricular acupuncture

Other: Thread Embedding AcupunctureOther: Auricular acupunctureOther: Standard treatment

Standard treatment

ACTIVE COMPARATOR

Standard treatment

Other: Standard treatment

Interventions

Thread Embedding Acupuncture is applied at acupoints including CV-12, CV-13, ST-36, PC-6, BL-17, BL-18, BL-21 on both sides of the body every 2 weeks, totaling 2 sessions over 4 weeks of intervention.

Acupuncture + Standard treatment

Auricular acupuncture is administered using adhesive patches with small needles (0.25 x 1.3 mm) placed at acupoints TF4, AH6, CO12, CO4, CO2 once a week, totaling 4 sessions over the 4-week intervention period.

Acupuncture + Standard treatment

Standard treatment, continuously administered over the 4-week intervention period, involves standard doses of proton pump inhibitors, additional antacids as needed, and lifestyle modifications.

Acupuncture + Standard treatmentStandard treatment

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Men or women aged from 18 to 60 Years
  • GerdQ score of eight or higher
  • Having heartburn and/or regurgitation on two days per week or more
  • Diagnosis of GERD with Liver Qi Invading Stomach Pattern

You may not qualify if:

  • Any prior endoscopy-confirmed structural diseases
  • Uncontrolled inflammatory bowel disease, chronic or genetic conditions, alcohol or drug abuse history
  • Alarming symptoms indicating gastric cancer, complicated ulcers, or serious illnesses
  • History of esophageal or gastrointestinal surgery
  • Current use of medications impacting GERD treatment or assessment
  • Recent (within two weeks) Western Medicine or Traditional Medicine treatment for GERD
  • History of hypersensitivity reactions to any components involved in the intervention
  • Pregnancy or breastfeeding
  • Current participation in any other clinical trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Medical Center HCMC - Branch no.3, University of Medicine and Pharmacy at Ho Chi Minh City

Ho Chi Minh City, 700000, Vietnam

Location

Related Publications (7)

  • Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA. 2020 Dec 22;324(24):2536-2547. doi: 10.1001/jama.2020.21360.

    PMID: 33351048BACKGROUND
  • Luo Z, Hu X, Chen C, Zhu L, Zhang W, Shen Y, He J. Effect of Catgut Embedment in Du Meridian Acupoint on Mental and Psychological Conditions of Patients with Gastroesophageal Reflux Disease. Evid Based Complement Alternat Med. 2020 Sep 22;2020:5415813. doi: 10.1155/2020/5415813. eCollection 2020.

    PMID: 33029166BACKGROUND
  • Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329. doi: 10.1038/ajg.2012.444. Epub 2013 Feb 19. No abstract available.

    PMID: 23419381BACKGROUND
  • Hunt R, Armstrong D, Katelaris P, Afihene M, Bane A, Bhatia S, Chen MH, Choi MG, Melo AC, Fock KM, Ford A, Hongo M, Khan A, Lazebnik L, Lindberg G, Lizarzabal M, Myint T, Moraes-Filho JP, Salis G, Lin JT, Vaidya R, Abdo A, LeMair A; Review Team:. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017 Jul;51(6):467-478. doi: 10.1097/MCG.0000000000000854. No abstract available.

    PMID: 28591069BACKGROUND
  • Sun QH, Li TT, Huang MT, Wang MY, Xiao X, Bai XH. [Acupoint selection rules in treating gastroesophageal reflux disease with acupuncture in China based on data mining]. Zhongguo Zhen Jiu. 2020 Dec 12;40(12):1374-8. doi: 10.13703/j.0255-2930.20191107-0003. Chinese.

    PMID: 33415885BACKGROUND
  • Zhu J, Guo Y, Liu S, Su X, Li Y, Yang Y, Hou L, Wang G, Zhang J, Chen JJ, Wang Q, Wei R, Wei W. Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis. Acupunct Med. 2017 Oct;35(5):316-323. doi: 10.1136/acupmed-2016-011205. Epub 2017 Jul 8.

    PMID: 28689187BACKGROUND
  • El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871-80. doi: 10.1136/gutjnl-2012-304269. Epub 2013 Jul 13.

    PMID: 23853213BACKGROUND

MeSH Terms

Conditions

Gastroesophageal Reflux

Interventions

Acupuncture, Ear

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Acupuncture TherapyComplementary TherapiesTherapeuticsAuriculotherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

November 27, 2023

First Posted

December 5, 2023

Study Start

December 6, 2023

Primary Completion

March 18, 2024

Study Completion

March 18, 2024

Last Updated

March 20, 2024

Record last verified: 2024-03

Locations